- This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
- Top stories: WHO backs COVID-19 antibody treatment; Sweden eyes more booster doses; South Korea reports highest ever daily increase in COVID-19 cases.
Have you read?
1. How COVID-19 is affecting the globe
Confirmed cases of COVID-19 have passed 230.6 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.72 million. More than 6.03 billion vaccination doses have been administered globally, according to Our World in Data.
More than half of Australia's adult population are now fully vaccincated against COVID-19, in a milestone towards the easing of restrictions.
The European Medicines Agency hopes to decide in early October whether to endorse a third booster dose of the Pfizer/BioNTech COVID-19 vaccine.
Viet Nam has pushed backed the reopening of the resort island of Phu Quoc to foreign visitors until November. It comes as insufficient vaccine supplies mean they failed to hit targets to vaccinating locals.
South Korea has recorded its highest ever number of confirmed daily COVID-19 cases - 2,434.
Singapore has also reported its highest daily COVID-19 case rise since the start of the pandemic - 1,504.
Novavax and its partner, the Serum Institute of India, have applied to the World Health Organization for emergency use listing of Novavax's COVID-19 vaccine.
Yemen has received its third batch of COVID-19 vaccines through the COVAX global vaccine-sharing scheme.
2. WHO-backing for COVID-19 treatment
A World Health Organization panel has recommended the use of Regeneron and Roche's COVID-19 antibody cocktail for patients at high risk of hospitalization and those severely ill with no natural antibodies.
The treatment has already been granted US emergency use authorization. It's currently under review in Europe, while Britain approved it last month.
While acknowledging costs associated with the treatment, the WHO panel said that given the recorded benefits of the therapy, "the recommendations should provide a stimulus to engage all possible mechanisms to improve global access to the intervention and associated testing".
In a separate statement, the WHO called on Regeneron to lower prices and distribute the treatment equitably worldwide, especially in low- and middle-income countries. The agency also urged the firms to transfer tech to help make biosimilars.
India’s leading COVID-19 last-mile responders
Each of our Top 50 social enterprise last mile responders and multi-stakeholder initiatives is working across four priority areas of need: Prevention and protection; COVID-19 treatment and relief; inclusive vaccine access; and securing livelihoods. The list was curated jointly with regional hosts Catalyst 2030’s NASE and Aavishkaar Group. Their profiles can be found on www.wef.ch/lastmiletop50india.
Top Last Mile Partnership Initiatives to collaborate with:
#BackTheFrontline - Dasra
Covid Action Collab
Covid Livelihoods Coalition – CoLive
Migrants Resilience Collaborative
Rapid Rural Community Response (RCRC)
Rural Access Coalition
Saath Nirbhar - vartaLeap Coalition and ComMutiny
Sanjha Collective - Goonj
Top 50 Last Mile Responders to get behind:
Barefoot College International
Center for Wildlife Studies
Society Of Development Alternatives
Doctors For You
Dream a Dream
Eleutheros Christian Society
Every Infant Matters
Healing Fields Foundation
Indian Society of Agribusiness Professionals
MAHAN Trust, Melghat
Mann Deshi Foundation
Mission Oxygen - Democracy
SEWA Cooperative Federation
Spandan Samaj Seva Samiti
Study Hall Educational Foundation (SHEF)
Sustainable Environment and Ecological Development Society (SEEDS)
Transforming Rural India Foundation
Ziqitza Health Care Limited
3. Sweden eyes giving more booster shot
Sweden is considering giving a third booster dose of COVID-19 vaccines to more of its population over concerns about waning protection from two shots.
Sweden has vaccinated 83% of the population aged over 16 with one dose and 76% with two doses. The country's public health agency recently identified some 40,000 people in need of a third dose, but said on Thursday more could soon be eligible.
"There are signals from abroad that indicate the protection from the vaccination is fading after some time, especially in those who are older," Public Health Agency official Sara Byfors told a news conference. "It is important to meet that with a third dose."